• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于神经内分泌肿瘤中癌组织特征描述的VERDICT MRI聚类分析

Cluster Analysis of VERDICT MRI for Cancer Tissue Characterization in Neuroendocrine Tumors.

作者信息

Lundholm Lukas, Montelius Mikael, Jalnefjord Oscar, Schoultz Elin, Forssell-Aronsson Eva, Ljungberg Maria

机构信息

Department of Medical Radiation Sciences, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

Department of Medical Physics and Biomedical Engineering, Sahlgrenska University Hospital, Gothenburg, Sweden.

出版信息

NMR Biomed. 2025 Jun;38(6):e70050. doi: 10.1002/nbm.70050.

DOI:10.1002/nbm.70050
PMID:40296332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12038086/
Abstract

Diffusion MRI models accounting for varying diffusion times and high b-values, such as VERDICT, hold potential for non-invasively characterizing tumor tissue types, potentially enabling improved tumor grading, and treatment evaluation. Furthermore, cluster analysis can aid in identifying multidimensional patterns in the diffusion MRI (dMRI) data that are not apparent when analyzing individual parameters in isolation. The aim of this study was to evaluate how well cluster analysis of VERDICT parameters can be used for intratumor tissue characterization compared to ADC in a mouse model of human small intestine neuroendocrine tumor (GOT1), and to validate the method by histological analysis. Mice implanted with GOT1 were irradiated and subsequently imaged using a dMRI protocol designed for estimation of VERDICT parameters and ADC values. Histological analysis using hematoxylin and eosin (H&E), Masson's trichrome, and Ki67 staining identified three distinct tumor tissue types: necrotic, fibrotic, and viable tumor tissue. ROIs were drawn on regions of high and low ADC, which spatially matched with necrosis or fibrosis, and viable tumor tissue, respectively. Among the VERDICT parameters, the cell radius index (R) was most effective in distinguishing between necrotic and fibrotic tissue, whereas the intracellular fraction (f) was the most effective in differentiating viable from non-viable tissue. A Gaussian mixture model (GMM) of three clusters, representing each tumor tissue type, was fitted to R and f of all tumor voxel data. VERDICT cluster maps corresponded well with the histology classification maps overall. Fibrotic tissue corresponded best with the cluster of low f and low R, necrotic tissue with the cluster of low f and high R, and viable tumor tissue with the cluster of high f and intermediate R. In conclusion, GMM cluster analysis of VERDICT MRI data shows potential in differentiating necrotic, fibrotic, and viable tumor tissue in irradiated GOT1 tumors.

摘要

扩散加权磁共振成像(Diffusion MRI)模型,如VERDICT,考虑了不同的扩散时间和高b值,具有无创性表征肿瘤组织类型的潜力,有可能改善肿瘤分级和治疗评估。此外,聚类分析有助于识别扩散加权磁共振成像(dMRI)数据中的多维模式,而单独分析单个参数时这些模式并不明显。本研究的目的是评估在人小肠神经内分泌肿瘤(GOT1)小鼠模型中,与表观扩散系数(ADC)相比,VERDICT参数的聚类分析用于肿瘤内组织表征的效果如何,并通过组织学分析验证该方法。将GOT1植入小鼠体内,进行照射,随后使用旨在估计VERDICT参数和ADC值的dMRI方案进行成像。使用苏木精和伊红(H&E)、Masson三色染色和Ki67染色进行组织学分析,确定了三种不同的肿瘤组织类型:坏死、纤维化和存活肿瘤组织。在高ADC和低ADC区域绘制感兴趣区(ROI),分别与坏死或纤维化区域以及存活肿瘤组织在空间上匹配。在VERDICT参数中,细胞半径指数(R)在区分坏死组织和纤维化组织方面最有效,而细胞内分数(f)在区分存活组织和非存活组织方面最有效。将代表每种肿瘤组织类型的三个聚类的高斯混合模型(GMM)拟合到所有肿瘤体素数据的R和f上。VERDICT聚类图总体上与组织学分类图吻合良好。纤维化组织与低f和低R的聚类最匹配,坏死组织与低f和高R的聚类最匹配,存活肿瘤组织与高f和中等R的聚类最匹配。总之,VERDICT MRI数据的GMM聚类分析在区分照射后GOT1肿瘤中的坏死、纤维化和存活肿瘤组织方面显示出潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/708d06c275c6/NBM-38-e70050-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/e77dbce1ec3b/NBM-38-e70050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/c51078484d15/NBM-38-e70050-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/8466191145a5/NBM-38-e70050-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/b8f682b6f636/NBM-38-e70050-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/a2beb9c561a9/NBM-38-e70050-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/61a03b98dc00/NBM-38-e70050-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/8c6bc70ccd67/NBM-38-e70050-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/708d06c275c6/NBM-38-e70050-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/e77dbce1ec3b/NBM-38-e70050-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/c51078484d15/NBM-38-e70050-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/8466191145a5/NBM-38-e70050-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/b8f682b6f636/NBM-38-e70050-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/a2beb9c561a9/NBM-38-e70050-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/61a03b98dc00/NBM-38-e70050-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/8c6bc70ccd67/NBM-38-e70050-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea95/12038086/708d06c275c6/NBM-38-e70050-g008.jpg

相似文献

1
Cluster Analysis of VERDICT MRI for Cancer Tissue Characterization in Neuroendocrine Tumors.用于神经内分泌肿瘤中癌组织特征描述的VERDICT MRI聚类分析
NMR Biomed. 2025 Jun;38(6):e70050. doi: 10.1002/nbm.70050.
2
VERDICT MRI for Prostate Cancer: Intracellular Volume Fraction versus Apparent Diffusion Coefficient.MRI 检测前列腺癌:细胞内容积分数与表观扩散系数。
Radiology. 2019 May;291(2):391-397. doi: 10.1148/radiol.2019181749. Epub 2019 Apr 2.
3
Microstructural characterization of normal and malignant human prostate tissue with vascular, extracellular, and restricted diffusion for cytometry in tumours magnetic resonance imaging.通过肿瘤磁共振成像中的血管、细胞外和受限扩散对正常和恶性人类前列腺组织进行微观结构表征以用于细胞计数。
Invest Radiol. 2015 Apr;50(4):218-27. doi: 10.1097/RLI.0000000000000115.
4
VERDICT MRI for radiation treatment response assessment in neuroendocrine tumors.磁共振成像在神经内分泌肿瘤放射治疗反应评估中的应用。
NMR Biomed. 2022 Jun;35(6):e4680. doi: 10.1002/nbm.4680. Epub 2022 Jan 24.
5
Non-invasive assessment of glioma microstructure using VERDICT MRI: correlation with histology.使用 VERDICT MRI 无创评估脑胶质瘤的微观结构:与组织学的相关性。
Eur Radiol. 2019 Oct;29(10):5559-5566. doi: 10.1007/s00330-019-6011-8. Epub 2019 Mar 19.
6
Prostate MR image quality of apparent diffusion coefficient maps versus fractional intracellular volume maps from VERDICT MRI using the PI-QUAL score and a dedicated Likert scale for artefacts.使用 PI-QUAL 评分和专用的伪影李克特量表评估 VERDICT MRI 的表观扩散系数图与细胞内分数体积图的前列腺 MR 图像质量。
Eur J Radiol. 2023 Nov;168:111109. doi: 10.1016/j.ejrad.2023.111109. Epub 2023 Sep 22.
7
A Population-Based Gaussian Mixture Model Incorporating 18F-FDG PET and Diffusion-Weighted MRI Quantifies Tumor Tissue Classes.一种结合18F-FDG PET和扩散加权MRI的基于人群的高斯混合模型可量化肿瘤组织类别。
J Nucl Med. 2016 Mar;57(3):473-9. doi: 10.2967/jnumed.115.163972. Epub 2015 Dec 10.
8
Neuroendocrine liver metastases: Value of apparent diffusion coefficient and enhancement ratios for characterization of histopathologic grade.神经内分泌肝脏转移瘤:表观扩散系数及强化率在组织病理学分级特征描述中的价值
J Magn Reson Imaging. 2016 Dec;44(6):1432-1441. doi: 10.1002/jmri.25320. Epub 2016 May 26.
9
Comprehensive Brain Tumour Characterisation with VERDICT-MRI: Evaluation of Cellular and Vascular Measures Validated by Histology.使用VERDICT-MRI进行脑肿瘤综合特征分析:经组织学验证的细胞和血管测量评估
Cancers (Basel). 2023 Apr 27;15(9):2490. doi: 10.3390/cancers15092490.
10
Microstructure Characterization of Bone Metastases from Prostate Cancer with Diffusion MRI: Preliminary Findings.前列腺癌骨转移的扩散磁共振成像微观结构特征:初步研究结果
Front Oncol. 2018 Feb 16;8:26. doi: 10.3389/fonc.2018.00026. eCollection 2018.

本文引用的文献

1
Advanced Diffusion-Weighted MRI for Cancer Microstructure Assessment in Body Imaging, and Its Relationship With Histology.体部成像中用于癌症微结构评估的高级扩散加权 MRI 及其与组织学的关系。
J Magn Reson Imaging. 2024 Oct;60(4):1278-1304. doi: 10.1002/jmri.29144. Epub 2023 Nov 30.
2
Tissue fibrosis induced by radiotherapy: current understanding of the molecular mechanisms, diagnosis and therapeutic advances.放疗诱导的组织纤维化:分子机制、诊断及治疗进展的最新认识。
J Transl Med. 2023 Oct 9;21(1):708. doi: 10.1186/s12967-023-04554-0.
3
Joint estimation of relaxation and diffusion tissue parameters for prostate cancer with relaxation-VERDICT MRI.
利用弛豫-VERDICT MRI 对前列腺癌的弛豫和扩散组织参数进行联合估计。
Sci Rep. 2023 Feb 21;13(1):2999. doi: 10.1038/s41598-023-30182-1.
4
Local diffusion in the extracellular space of the brain.大脑细胞外空间的局部扩散。
Neurobiol Dis. 2023 Feb;177:105981. doi: 10.1016/j.nbd.2022.105981. Epub 2022 Dec 26.
5
Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.转移性结直肠癌:ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2023 Jan;34(1):10-32. doi: 10.1016/j.annonc.2022.10.003. Epub 2022 Oct 25.
6
Cancer-Associated Fibroblasts: Tumorigenicity and Targeting for Cancer Therapy.癌症相关成纤维细胞:致瘤性及癌症治疗靶点
Cancers (Basel). 2022 Aug 12;14(16):3906. doi: 10.3390/cancers14163906.
7
VERDICT MRI for radiation treatment response assessment in neuroendocrine tumors.磁共振成像在神经内分泌肿瘤放射治疗反应评估中的应用。
NMR Biomed. 2022 Jun;35(6):e4680. doi: 10.1002/nbm.4680. Epub 2022 Jan 24.
8
ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of patients with metastatic breast cancer.欧洲肿瘤内科学会转移性乳腺癌患者诊断、分期及治疗临床实践指南
Ann Oncol. 2021 Dec;32(12):1475-1495. doi: 10.1016/j.annonc.2021.09.019. Epub 2021 Oct 19.
9
MRI with ultrahigh field strength and high-performance gradients: challenges and opportunities for clinical neuroimaging at 7 T and beyond.具有超高场强和高性能梯度的磁共振成像:7T及更高场强下临床神经成像面临的挑战与机遇
Eur Radiol Exp. 2021 Aug 26;5(1):35. doi: 10.1186/s41747-021-00216-2.
10
Fibroblasts in cancer dormancy: foe or friend?癌症休眠中的成纤维细胞:敌还是友?
Cancer Cell Int. 2021 Mar 26;21(1):184. doi: 10.1186/s12935-021-01883-2.